Metrics manifesting the strongest concurrent validity with providers identified from these records related to those who co-prescribed benzodiazepines (e.g., valium) and high levels of opioid analgesics (e.g., oxycodone), as well as those who wrote temporally overlapping prescriptions. The report concludes with a discussion of a variety of uses to which these metrics may be put, as well as problems and opportunities related to their use. (Publisher abstract modified)
Downloads
Similar Publications
- Birmingham Treatment Alternatives to Street Crime (TASC): Meeting Women's Needs Through Coordinated Case Management
- Substance Abuse Intervention Division (SAID): New York City Department of Corrections' Drug Treatment Program for Women Offenders
- Hair Assays for Drugs of Abuse in a Probation Population: Implementation of a Pilot Study in a Correctional Field Setting; Final Report